Prices for key vitamins are firming, driven by limited offers and increased spot market activity. With many end-users securing forward contracts, current trading is shaped by cautious buying and persistent supply chain pressures.
HighlightsVitamin E 50%: Prices are being pushed upward by limited offers and active spot trading, while most end-users are already covered for Q2 and Q3 at lower contract levels.Vitamin A 1000: Suppliers aim to raise prices and limit offers, but the market is currently stable with most volumes for Q2 and Q3 already contracted.Vitamin D3 500: Prices remain stable at elevated levels as cautious buying and secured Q2 contracts keep the market balanced.D-Calpan: Prices have surged due to supply constraints and geopolitical pressure, prompting buyers to secure forward coverage while traders drive spot activity.Vitamin B3: Prices are rising mainly in the spot market due to supply concerns, though most forward contracts through Q2 – Q4 2026 are already secured at lower levels.In partnership with Feed Additive Prices Vitamin E 50%
Suppliers are maintaining a firm stance, and their offers are limited. There is a persistent eagerness to raise prices, stemming from a time of low price levels. Currently, traders are primarily active in the spot market, filling gaps and driving up prices across the board. Meanwhile, many end-users have successfully locked in their Q2 and Q3 volumes at lower prices in advance and are now concentrating on executing contracts in a timely manner.
Vitamin A 1000
The dynamics we are witnessing are reminiscent of those seen with vitamin E, as suppliers strive to push prices higher, breaking free from the recent lows. There is a strong eagerness among suppliers to escape the low price levels, often leading them to hold back on offers or propose higher prices. Yet it appears the price has stabilised for the time being. Currently, trading activity is mainly dominated by traders handling spot volumes, while manufacturers remain cautious and tentative with their offers. A significant portion of Q2 and Q3 has already been contracted by end-users.
Vitamin D3 500
The market for vitamin D3 500 remains quite stable, although prices are still elevated compared to last year. With the current price levels, buyers are exercising caution, opting to purchase only what they need, which results in a thinner pipeline and helps maintain stable prices at this higher mark. There are no strong indications that prices will surge further, nor is there an expectation for a decline in the near future. Most contracts for the second quarter have already been secured.
VITAMIN PRICES: Here the market prices of 3 important vitamins are tracked – check it out…Vitamin B2 80%
The vitamin B2 market has experienced a steady and calm pricing trend across most regions until recently, but it’s now showing signs of slight firming, aligning with a broader trend of a strengthening vitamin market. As we look to the future, most contracts for Q2 have been secured, and a healthy overlap into Q3 is already seen as well.
D-Calpan
Recent weeks have witnessed a significant surge in d-calpan prices, marking a notable shift after an extended period of stability at low levels. That had led the market into complacency, resulting in minimal interest in long positions. However, the ongoing geopolitical landscape has begun to strain the supply chain, revealing that immediate availability is not as robust as anticipated, which has in turn exerted upward pressure on prices. As a result, buyers have reacted swiftly, securing forward cover, and the upper end of the pricing spectrum has largely been influenced by traders engaging in spot purchasing and filling gaps in availability. Contracts for Q2 and part of Q3 have already been established.
Vitamin B3
While a price increase has been observed, it’s important to note that during the earlier price hike this year, many buyers proactively secured long positions extending into 2026. Consequently, the current upward price pressure is primarily driven by spot transactions alongside potential shortages or elevated raw material prices influenced by the ongoing situation in Iran. Interestingly, average contract prices remain lower than anticipated, as contracts for Q2, Q3, and part of Q4 have already been finalised.
Biotin
Recently, a modest uptick was noted in prices for both pure biotin and its popular diluted counterpart, biotin 2%, but as of now, the market appears stable, with contracts already secured for materials extending well into 2026.
Vitamin C 35% mono
A modest price increase for vitamin C products has been observed, reflecting trends in the broader vitamin market, although it remains insignificant at this stage. Despite ongoing global geopolitical tensions, the supply and demand for this product remain balanced, keeping prices fairly low and ensuring a consistent supply, with container freight rates showing minimal changes in most cases and a significant portion of 2026 already under contract.
